United States · FDA National Drug Code directory
Nicotine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0536-1337_09bfc71c-cebe-4d12-8c99-d5b2017f5a79
- Product NDC
- 0536-1337
- Form
- LOZENGE
- Composition / generic term
- nicotine polacrilex
- Labeler
- Rugby Laboratories, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210917
- Source listing expiry
- 20261231
Source-listed ingredients
- NICOTINE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BOTTLE, PLASTIC in 1 BOX (0536-1337-09) / 24 LOZENGE in 1 BOTTLE, PLASTIC · 0536-1337-09
- 1 BOTTLE, PLASTIC in 1 BOX (0536-1337-35) / 24 LOZENGE in 1 BOTTLE, PLASTIC · 0536-1337-35
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →